Search Results - Arlene Berman

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Long-Term Follow-Up for Locally Advanced and Inflammatory Breast Cancer Patients Treated With Multimodality Therapy

    Long-Term Follow-Up for Locally Advanced and Inflammatory Breast Cancer Patients Treated With Multimodality Therapy by Jennifer A. Low, Arlene Berman, Seth M. Steinberg, David N. Danforth, Marc E. Lippman, Sandra M. Swain

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Phase II Trial of Ixabepilone, an Epothilone B Analog, in Patients With Metastatic Breast Cancer Previously Untreated With Taxanes

    Phase II Trial of Ixabepilone, an Epothilone B Analog, in Patients With Metastatic Breast Cancer Previously Untreated With Taxanes by Neelima Denduluri, Jennifer A. Low, James J. Lee, Arlene Berman, Janice M. Walshe, Ujala Vatas, Catherine K. Chow, Seth M. Steinberg, Sherry Yang, Sandra M. Swain

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection

    EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection by Sinchita Roy‐Chowdhuri, Liqiang Xi, Trinh H. Pham, Jeffrey C. Hanson, Jaime Rodriguez‐Canales, Arlene Berman, Arun Rajan, Giuseppe Giaccone, Michael R. Emmert‐Buck, Mark Raffeld, Armando Filie

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors

    Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors by Giuseppe Giaccone, Arun Rajan, Arlene Berman, Ronan J. Kelly, Éva Szabó, Ariel López-Chávez, Jane B. Trepel, Min-Jung Lee, Liang Cao, Igor Espinoza‐Delgado, John Spittler, Patrick J. Loehrer

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Cardiac Toxicity and Efficacy of Trastuzumab Combined with Pertuzumab in Patients with Trastuzumab-Insensitive Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

    Cardiac Toxicity and Efficacy of Trastuzumab Combined with Pertuzumab in Patients with Trastuzumab-Insensitive Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast C... by Chia C. Portera, Janice M. Walshe, Douglas R. Rosing, Neelima Denduluri, Arlene Berman, Ujala Vatas, Margarita Velarde, Catherine K. Chow, Seth M. Steinberg, Diana Nguyen, Sherry X. Yang, Sandra M. Swain

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Influence of Garlic (<i>Allium sativum</i>) on the Pharmacokinetics of Docetaxel

    Influence of Garlic (<i>Allium sativum</i>) on the Pharmacokinetics of Docetaxel by Michael C. Cox, Jennifer A. Low, James Lee, Janice M. Walshe, Neelima Denduluri, Arlene Berman, Matthew G. Permenter, William P. Petros, Douglas K. Price, William D. Figg, Alex Sparreboom, Sandra M. Swain

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia

    Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia by Peter D. Burbelo, Sarah K. Browne, Elizabeth P. Sampaio, Giuseppe Giaccone, Rifat Zaman, Ervand Kristosturyan, Arun Rajan, Li Ding, Kathryn H. Ching, Arlene Berman, João Bosco Oliveira, Amy P. Hsu, Caitlin M. Klimavicz, Michael J. Iadarola, Steven M. Holland

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial

    Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial by Anish Thomas, Arun Rajan, Arlene Berman, Yusuke Tomita, Christina Brzezniak, Min-Jung Lee, Sunmin Lee, Alexander Ling, Aaron John Spittler, Corey A. Carter, Udayan Guha, Yisong Wang, Éva Szabó, Paul S. Meltzer, Seth M. Steinberg, Jane B. Trepel, Patrick J. Loehrer, Giuseppe Giaccone

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial

    Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial by Arun Rajan, Corey A. Carter, Arlene Berman, Liang Cao, Ronan J. Kelly, Anish Thomas, Sean Khozin, Ariel Lopez Chavez, Isabella Bergagnini, Barbara Scepura, Éva Szabó, Min-Jung Lee, Jane B. Trepel, Sarah K. Browne, Lindsey B. Rosen, Yunkai Yu, Seth M. Steinberg, Helen X. Chen, Gregory J. Riely, Giuseppe Giaccone

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer

    Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer by Suparna Wedam, Jennifer A. Low, Sherry X. Yang, Catherine K. Chow, Peter L. Choyke, David N. Danforth, Stephen M. Hewitt, Arlene Berman, Seth M. Steinberg, David J. Liewehr, Jonathan F. Plehn, Arpi Doshi, Dave Thomasson, Nicole McCarthy, Hartmut Koeppen, Mark E. Sherman, JoAnne Zujewski, Kevin Camphausen, Helen Chen, Sandra M. Swain

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial

    Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial by Ariel López-Chávez, Anish Thomas, Arun Rajan, Mark Raffeld, Betsy Morrow, Ronan J. Kelly, Corey Allan Carter, Udayan Guha, Keith Killian, Christopher Lau, Zied Abdullaev, Liqiang Xi, Svetlana Pack, Paul S. Meltzer, Christopher L. Corless, Alan Sandler, Carol Beadling, Andrea Warrick, David J. Liewehr, Seth M. Steinberg, Arlene Berman, Austin Doyle, Éva Szabó, Yisong Wang, Giuseppe Giaccone

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma

    Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma by Arun Rajan, Christopher R. Heery, Anish Thomas, Andrew L. Mammen, Susan Perry, Geraldine O’Sullivan Coyne, Udayan Guha, Arlene Berman, Éva Szabó, Ravi A. Madan, Leomar Y. Ballester, Stefania Pittaluga, Renee N. Donahue, Yo-Ting Tsai, Lauren M. Lepone, Kevin M. Chin, Fiona Ginty, Anup Sood, Stephen M. Hewitt, Jeffrey Schlom, Raffit Hassan, James L. Gulley

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: